Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: A systematic review and meta-analysis

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 3, 2014, Pages 366-370

  Ungprasert, Patompong ^a,b   Sanguankeo, Anawin ^b   Upala, Sikarin ^b   Knight, Eric L ^a  

^a Bassett Medical Center and Columbia University College of Physicians and Surgeons ^*  (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Epidemiology; Giant cell arteritis; Malignancy; Meta analysis; Polymyalgia rheumatica

Indexed keywords

ARTICLE; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; GIANT CELL ARTERITIS; HAZARD RATIO; HUMAN; RHEUMATIC POLYMYALGIA; SELECTION BIAS; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; COMPLICATION; INCIDENCE; META ANALYSIS; NEOPLASMS; RISK FACTOR;

GIANT CELL ARTERITIS; HUMANS; INCIDENCE; NEOPLASMS; POLYMYALGIA RHEUMATICA; RISK FACTORS;

EID: 84919597136     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2014.06.004     Document Type: Article

References (21)

1. Borchers A.T., Gershwin M.E. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev 2012, 11:A544-54.
2. Smeeth L., Cook C., Hall A.J. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 2006, 65:1093-1098.
3. Ungprasert P., Leeaphorn N., Hosiriluck N., Chaiwatcharayut W., Ammannagari N., Raddatz D.A. Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in Asian population. ISRN Rheumatol 2013, 2013:509354.
4. Smitten A.L., Simon T.A., Hochberg M.C., Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 2008, 10:R45.
5. Gayed M., Bernatsky S., Ramsey-Goldman, Clarke A., Gordon C. Lupus and cancer. Lupus 2009, 18:479-485.
6. Liozin E., Loustad V., Fauchais, Soria P., Ly K., Ouattara B., et al. Concurrent temporal (giant cell) arteritis and malignancy: report of 20 patients with review of the literature. J Rheumatol 2006, 33:1606-1614.
7. Sidhom O.A., Basalaev M., Sigal L.H. Renal cell carcinoma presenting as polymyalgia rheumatica. Resolution after nephrectomy. Arch Intern Med 1993, 153:2043-2045.
8. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010, 25:603-605.
9. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
10. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Br Med J 2003, 327:557-560.
11. Schaufelberger C., Bengtsson B.A., Andersson R. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J Rheumatol 1995, 34:261-264.
12. Gonzalez-Gay M.A., Lopez-Diaz M.J., Martinez-Lado L., Pena-Sagedro J.L., Lopez-Agreda H., Miranda-Filloy J.A., et al. Cancer in biopsy proven giant cell arteritis. A population based study. Semin Arthritis Rheum 2007, 37:156-163.
13. Ninan J., Nguyen A.M., Cole A., Rischmueller M., Dodd T., Roberts-Thomson P., et al. Mortality in patients with biopsy proven giant cell arteritis: a southern Australian population-based study. J Rheumatol 2011, 38:2215-2217.
14. Haga H.J., Eide G.E., Brun J., Johansen A., Langmark F. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1993, 20:1335-1339.
15. Myklebust G., Wilsgaard T., Jacobsen B.K., Gran J.T. No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol 2002, 29:2143-2147.
16. Ji J., Liu X., Sunquist K., Sunquist J., Hemminki K. Cancer risk in patients with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden. Rheumatology (Oxford) 2010, 49:1158-1163.
17. Kermani T.A., Schafer V.S., Crowson C.S., Hunder G.G., Gabriel S.E., Ytterberg S.R., et al. Malignancy risk in patients with giant cell arteritis. A population-based study. Arthritis Care Res (Hoboken) 2010, 62:149-154.
18. Hill C.L., Cole A., Rischmuller M., Dodd T., Coleman M., Tucker G., et al. Risk of cancer in patients with biopsy-proven giant cell arteritis. Rheumatology (Oxford) 2010, 49:756-759.
19. Muller S., Hider S.L., Belcher J., Helliwell T., Mallen C.D. Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database. Ann Rheum Dis 2013, [Epub ahead of print].
20. Naschitz J.E., Slobodin G., Yeshurun D., Rozenbaum M., Rosner I. A polymyalgia rheumatica-like syndrome as presentation of metastatic cancer. J Clin Rheumatol 1996, 2:305-308.
21. Randazzo C.T., Bernard A.W., Rund D.A. Metastatic prostate cancer mimicking polymyalgia rheumatica. Case Rep Emerg Med 2011, 2011:695320.